Project description
Ending endometriosis diagnostic delay
One of the most common chronic diseases in fertile women, endometriosis affects 14 million women across the EU. The disease is caused by tissue from the uterus growing mainly in the lower abdomen. The most common symptoms are intense pain during periods and intercourse, and chronic pelvic pain. However, it takes years for the disease to be correctly diagnosed, and sufferers are at greater risk of ovarian cancer than the rest of the female population. The EU-funded TRENDO project will address the main problems in endometriosis diagnosis and therapy. Bringing together clinical and translational science experts and industry partners from six European and South American countries, the project will develop non-invasive biomarkers and testing, which will shorten diagnostic delay and reduce unequal access to expensive healthcare.
Fields of science
Programme(s)
Coordinator
48149 Muenster
Germany
See on map
Participants (7)
17177 Stockholm
See on map
50411 Tartu
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
6200 MD Maastricht
See on map
02 091 Warszawa
See on map
1000 Ljubljana
See on map
48149 Munster
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
12618 Tallinn
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partners (1)
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
C1425FQB Buenos Aires
See on map